Good news for the millions of women who struggle with urinary tract infections (UTIs). The Food and Drug Administration (FDA) has approved a new drug, Blujepa, the first of a new class of oral ...

The Food and Drug Administration on Tuesday approved the first drug in a new class of antibiotics for treating urinary tract infections — the first time that’s happened in nearly 30 years.

Recently approved medications for resistant hypertension, uncomplicated UTIs and menopausal hot flashes show potential as ...

Urinary tract infections (UTIs) are among the most common ... On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years.

With significant survival improvements seen, the FDA has granted approval to retifanlimab for the first-line treatment of ...

The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs ... for the treatment of cUTIs in adults, including severe kidney ...

and urinary tract infections. According to the company’s safety information, doctors must advise their patients about using effective contraception during the therapy as the new treatment can ...

Focusing on a new antibiotic for UTIs, which haven’t had a novel therapy in decades, was intentional, Walmsley says. Half of ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...